Business - Briefly   

Unichem pact with Pliva of the U.S.

CHENNAI: Unichem Laboratories has entered into a product development, manufacturing and supply agreement with Pliva of the U.S. a wholly owned subsidiary of Pliva Pharmaceuticals, Zagreb, Croatia. Under the terms of the agreement, Pliva will fund certain development activity of the company in return for its conferring exclusively to Pliva to market certain of its generics under joint label in the U.S. markets. Unichem informed the BSE that it has recommended a dividend of Rs. 5 on equity share of Rs. 5 each for 2005-2006.

Printer friendly page  
Send this article to Friends by E-Mail

Stories in this Section

SBI posts higher net
Mittal sweetens bid for Arcelor
Court orders Administrators for M P Birla estates
Sensex drops another 450 points on selling
Bajaj Auto net profit up 47 p.c.
Tata Motors net at Rs. 1,728 cr.
J&K Bank profit up
Legal process outsourcing market share to grow to 6-7 per cent
Quality seed nuts being selected to control root-wilt disease
Federal Bank's operating profit up by 13 per cent
Rupee tumbles
Rs. 7,000 cr. investment for shipbuilding
Exchange rates
Bullion rates
TDSAT directive on differential tariff
RBI expands coverage of database
Doha Bank to open branch in Mumbai
Rejects plea of Saudi co.
IOB launches sale of gold coins
Unichem pact with Pliva of the U.S.
CyberMedia profit up 40 p.c.
Siemens division, Huawei-3Com tie-up
PNB net profit at Rs. 1,439 cr.
Corporation Bank hands over dividend to Govt.
New ED for Bank of India
Yamaha unveils new bike, Gladiator

Copyright © 2006, The Hindu. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu